Musculoskeletal manifestations in patients with malignant disease

Clinical Rheumatology

Volumn 29, Issue 2, 2010, Pages 181-188

  Gheita, Tamer A ^a   Ezzat, Yasser ^b   Sayed, Safaa ^a   El Mardenly, Ghada ^a   Hammam, Waleed ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b FAYOUM UNIVERSITY   (Egypt)

Author keywords

Drug induced rheumatic diseases; Neoplasia; Osteoporosis; Soft tissue rheumatism; Vasculitis

Indexed keywords

ANASTROZOLE; CARBOPLATIN; CREATININE; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; LETROZOLE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR; STEROID; UREA; ANTINEOPLASTIC AGENT; NITRILE; TRIAZOLE DERIVATIVE;

ADULT; ARTHRALGIA; ARTICLE; AVASCULAR NECROSIS; BEAM THERAPY; BLADDER CANCER; BONE DENSITY; BONE NECROSIS; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; CUTANEOUS VASCULITIS; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROMYALGIA; FROZEN SHOULDER; HEMATOLOGIC MALIGNANCY; HEPATITIS C VIRUS; HUMAN; HYPERTROPHIC OSTEOARTHROPATHY; KIDNEY FUNCTION; KIENBOECK DISEASE; LUNATE BONE; MAJOR CLINICAL STUDY; MALE; MONARTHRITIS; MUSCULOSKELETAL DISEASE; MYALGIA; NONHODGKIN LYMPHOMA; OSTEOLYSIS; OSTEOPOROSIS; OVARY CANCER; POLYARTHRITIS; PRIORITY JOURNAL; RADIUS; SIDE EFFECT; SOLID TUMOR; SPINE; STOMACH CANCER; TENOSYNOVITIS; VASCULITIS; AGED; ANALYSIS OF VARIANCE; ARTHROPATHY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MUSCLE DISEASE; NEOPLASM; NONPARAMETRIC TEST;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; MUSCULAR DISEASES; NEOPLASMS; NITRILES; OSTEOPOROSIS; STATISTICS, NONPARAMETRIC; TRIAZOLES;

EID: 77949901999     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1310-0     Document Type: Article

References (59)

1. JE Naschitz I Rosner 2008 Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy) Curr Opin Rheumatol 20 100 10.1097/BOR.0b013e3282f1ecd4 18281865 (Pubitemid 351339439)
2. S Carsons 1997 The association of malignancy with rheumatic and connective tissue diseases Semin Oncol 24 360 1:STN:280:DyaK2szlt1Cqtw%3D%3D 9208890
3. JE Naschitz I Rosner M Rozenbaum E Zuckerman D Yeshurun 1999 Rheumatic syndromes: clues to occult neoplasia Semin Arthritis Rheum 29 43 10.1016/S0049-0172(99)80037-7 1:STN:280:DyaK1Mzps1Giug%3D%3D 10468414 (Pubitemid 29383442)
4. JE Naschitz D Yeshurun I Rosner 2954 Rheumatic manifestations of occult cancer Cancer 1995 75
5. J Morel V Deschamps E Toussirot E Pertuiset C Sordet P Kieffer JM Berthelot H Champagne X Mariette B Combe 2008 Characterisitics and survival of 26 patients with paraneoplastic arthritis Ann Rheum Dis 67 244 10.1136/ard.2007.070086 1:STN:280:DC%2BD1c%2FisV2ktA%3D%3D 17604284 (Pubitemid 351183316)
6. X Mariette A de Roquancourt MF d'Agay C Gisselbrecht JP Clauvel E Oksenhendler 1988 Monoarthritis revealing non-Hodgkin's T-cell lymphoma of the synovium Arthritis Rheum 31 571 10.1002/art.1780310419 1:STN:280: DyaL1c7pt1Olsg%3D%3D 3258753
7. G Gridley JK McLaughlin A Ekbom L Klareskog HO Adami DG Hacker R Hoover JF Fraumeni Jr 1993 Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 85 307 10.1093/jnci/85.4.307 1:STN:280:DyaK3s7kvVehsQ%3D%3D 8426374
8. H Savin B Zimmermann 3rd RK Aaron NP Libbey J Khorsand JC Alper EV Lally 1991 Seronegative symmetric polyarthritis in Sezary syndrome J Rheumatol 18 464 1:STN:280:DyaK3MzhtFKiug%3D%3D 1856817
9. M Ehrenfeld H Gur Y Shonenfeld 1999 Rheumatologic features of hematologic disease Curr Opin Rheumatol 11 62 10.1097/00002281-199901000-00011 1:STN:280:DyaK1M7ht1SjsQ%3D%3D 9894632 (Pubitemid 29057583)
10. MJ Kransdorf 1995 Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location AJR Am J Roentgenol 164 129 1:STN:280:DyaK2M%2FptFWksw%3D%3D 7998525
11. TP Loughran Jr 1993 Clonal diseases of large granular lymphocytes Blood 82 1 8324214
12. JA Avina-Zubieta G Galindo-Rodriguez C Lavalle 1998 Rheumatic manifestations of hematologic disorders Curr Opin Rheumatol 10 86 10.1097/00002281-199801000-00013 1:STN:280:DyaK1c7htVCrsQ%3D%3D 9448995 (Pubitemid 28058520)
13. JA Rennie IA Auchterlonie 1991 Rheumatological manifestations of the leukaemias and graft versus host disease Baillieres Clin Rheumatol 5 231 10.1016/S0950-3579(05)80281-X 1:STN:280:DyaK38%2Fpslaitg%3D%3D 1756582
14. Yazici Y, Kagen LJ (2008) Malignancy and rheumatic disorders. In: Schur PH, Romain PL (eds) UptoDate, 1. http://www.uptodate.com/patients/content/topic. do?topicKey=~HrrJbxA8N5N6fO
15. CL Loprinzi J Duffy JN Ingle 1993 Postchemotherapy rheumatism J Clin Oncol 11 768 1:STN:280:DyaK3s3ktVajsw%3D%3D 8478669
16. MJ Kim YM Ye HS Park CH Suh 2006 Chemotherapy-related arthropathy J Rheumatol 33 1364 1:CAS:528:DC%2BD28XnslWjtL8%3D 16821271
17. LF Hutchins SJ Green PM Ravdin D Lew S Martino M Abeloff AP Lyss C Allred SE Rivkin CK Osborne 2005 Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102 J Clin Oncol 23 33 8313 8321 10.1200/JCO.2005.08.071 1:CAS:528:DC%2BD2MXhtlWhtrjK 16293862
18. I Sestak J Cuzick F Sapunar R Eastell JF Forbes AR Bianco AU Buzdar ATAC Trialists' Group 2008 Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis Lancet Oncol 9 9 866 872 10.1016/S1470-2045(08)70182-7 18703382 Epub 2008 Aug 12
19. F Boccardo A Rubagotti M Puntoni P Guglielmini D Amoroso A Fini G Paladini M Mesiti D Romeo M Rinaldini S Scali M Porpiglia C Benedetto N Restuccia F Buzzi R Franchi B Massidda V Distante D Amadori P Sismondi 2005 Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial J Clin Oncol 23 22 5138 5147 10.1200/JCO.2005.04.120 1:CAS:528:DC%2BD2MXpsFWmtb4%3D 16009955 Epub 2005 Jul 11 (Pubitemid 46224022)
20. JA Nabholtz 2008 Long-term safety of aromatase inhibitors in the treatment of breast cancer Ther Clin Risk Manag 4 1 189 204 1:CAS:528: DC%2BD1cXks1Sks70%3D 18728707
21. EA Perez RG Josse KI Pritchard JN Ingle S Martino BP Findlay TN Shenkier RG Tozer MJ Palmer LE Shepherd S Liu D Tu PE Goss 2006 Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17 J Clin Oncol 24 22 3629 3635 10.1200/JCO.2005.05.4882 1:CAS:528: DC%2BD28XovVSjsLc%3D 16822845 Epub 2006 Jul 5 (Pubitemid 46630537)
22. A Howell J Cuzick M Baum A Buzdar M Dowsett JF Forbes G Hoctin-Boes J Houghton GY Locker JS Tobias ATAC Trialists' Group 2005 Results of the ATAC (Arimidex, Tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 9453 60 62 10.1016/S0140-6736(04)17666-6 1:STN:280:DC%2BD2M%2FhsVartA%3D%3D 15639680 (Pubitemid 40082147)
23. PE Lønning J Geisler LE Krag B Erikstein Y Bremnes AI Hagen E Schlichting EA Lien ES Ofjord J Paolini A Polli G Massimini 2005 Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer J Clin Oncol 23 22 5126 5137 10.1200/JCO.2005.07.097 15983390 Epub 2005 Jun 27 (Pubitemid 46224021)
24. AJ Chien PE Goss 2006 Aromatase inhibitors and bone health in women with breast cancer J Clin Oncol 24 33 5305 5312 10.1200/JCO.2006.07.5382 1:CAS:528:DC%2BD28XhtlemurfM 17114665 (Pubitemid 46631378)
25. KD Crew H Greenlee J Capodice G Raptis L Brafman D Fuentes A Sierra DL Hershman 2007 Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer J Clin Oncol 25 25 3877 3883 10.1200/JCO.2007.10.7573 17761973 (Pubitemid 47477264)
26. CA Presant L Bosserman T Young M Vakil R Horns G Upadhyaya B Ebrahimi C Yeon F Howard 2007 Aromatase inhibitor-associated arthralgia and/or bone pain: frequency and characterization in non-clinical trial patients Clin Breast Cancer 7 10 775 778 10.3816/CBC.2007.n.038 1:CAS:528:DC%2BD2sXhsVeltbjP 18021478
27. NL Henry JT Giles D Ang M Mohan D Dadabhoy J Robarge J Hayden S Lemler K Shahverdi P Powers L Li D Flockhart V Stearns DF Hayes AM Storniolo DJ Clauw 2008 Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors Breast Cancer Res Treat 111 2 365 372 10.1007/s10549-007-9774-6 1:CAS:528:DC%2BD1cXptVCntLk%3D 17922185
28. L Morales P Neven D Timmerman H Wildiers ML Konstantinovic MR Christiaens PN Tan R Paridaens 2009 Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant Breast Cancer Res Treat 117 1 77 81 10.1007/s10549-008-0248-2 1:CAS:528:DC%2BD1MXpvFyitbc%3D 19048370
29. A Brufsky WG Harker JT Beck R Carroll E Tan-Chiu C Seidler J Hohneker L Lacerna S Petrone EA Perez 2007 Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer J Clin Oncol 25 7 829 836 10.1200/JCO.2005.05.3744 1:CAS:528:DC%2BD2sXjvVKmtL0%3D 17159193 Epub 2006 Dec 11 (Pubitemid 350002883)
30. U Kiltz J Brandt J Zochling J Braun 2007 Rheumatic manifestations of lymphoproliferative disorders Clin Exp Rheumatol 25 1 35 39 1:STN:280: DC%2BD2s3htlOmsg%3D%3D 17417988
31. AG Fam 2000 Paraneoplastic rheumatic syndromes Bailliere's Best Pract Res Clin Rheumatol 14 3 515 533 10.1053/berh.2000.0091 1:STN:280: DC%2BD3M%2FisVCkug%3D%3D
32. G Jesus A Barcelos C Neves J Crespo 2006 Rheumatic manifestations and neoplasms Acta Reumatol Port 31 4 305 321 17334043
33. A Dabrowska-Zimoń M Brzosko 2006 A review of paraneoplastic rheumatic syndromes Ann Acad Med Stetin 52 Suppl 2 17 22 17474176
34. PM Brooks 1992 Rheumatic manifestations of neoplasia Curr Opin Rheumatol 4 1 90 93 1:STN:280:DyaK387otFynsA%3D%3D 1543670
35. S Oztürkcan F Ozel S Doǧan Z Seyfikli A Hatipoǧlu 2003 The skin manifestations in patients with lung cancers Tuberk Toraks 51 1 23 26 15100900
36. R Kurzrock PR Cohen 1995 Cutaneous paraneoplastic syndromes in solid tumors Am J Med 99 6 662 671 10.1016/S0002-9343(99)80254-X 1:STN:280: DyaK287gs1ejsQ%3D%3D 7503090 (Pubitemid 26006448)
37. H Raffayova P Schultz F Malis 2000 Secondary hypertrophic osteoarthropathy in a patient with pulmonary carcinoma Bratisl Lek Listy 101 4 219 222 1:STN:280:DC%2BD3czpt1GqsQ%3D%3D 10914468
38. Y Abe S Kurita Y Ohkubo H Usui T Hashizume M Nakamura Y Ueyama T Fujino 2002 A case of pulmonary adenocarcinoma associated with hypertrophic osteoarthropathy due to vascular endothelial growth factor Anticancer Res 22 6B 3485 3488 12552943
39. J Fridlington J Weaver B Kelly E Kelly 2007 Secondary hypertrophic osteoarthropathy associated with solitary fibrous tumor of the lung J Am Acad Dermatol 57 5 Suppl S106 S110 10.1016/j.jaad.2006.10.045 17938018 (Pubitemid 47552646)
40. M Massarotti G Ciocia R Ceriani A Chiti B Marasini 2008 Metastatic gastric cancer presenting with shoulder-hand syndrome: a case report J Med Case Reports 2 240 10.1186/1752-1947-2-240 18652664
41. AL Cheville J Tchou 2007 Barriers to rehabilitation following surgery for primary breast cancer J Surg Oncol 95 5 409 418 10.1002/jso.20782 17457830 (Pubitemid 46697204)
42. C Sheehy JG Ryan M Kelly M Barry 2007 Palmar fasciitis and polyarthritis syndrome associated with non-small-cell lung carcinoma Clin Rheumatol 26 11 1951 1953 10.1007/s10067-007-0582-5 17310269 Epub 2007 Feb 20 (Pubitemid 47516985)
43. S Eyigor H Karapolat OK Korkmaz C Eyigor B Durmaz R Uslu M Uyar 2009 The frequency of fibromyalgia syndrome and quality of life in hospitalized cancer patients Eur J Cancer Care (Engl) 18 2 195 201 10.1111/j.1365-2354.2008.00997.x 1:STN:280:DC%2BD1M7ptlensg%3D%3D
44. O Fain M Hamidou P Cacoub B Godeau B Wechsler J Pariès J Stirnemann A Morin M Gatfosse T Hanslik N Belmatoug O Blètry R Cevallos I Delevaux E Fisher G Hayem G Kaplan C Le Hello L Mouthon C Larroche V Lemaire A Piette J Piette T Ponge X Puechal J Rossert R Sarrot D Sicard J Ziza M Kahn L Guillevin 2007 Vasculitides associated malignancies: analysis of sixty patients Arthritis Rheum 57 1473 10.1002/art.23085 18050165 (Pubitemid 350308846)
45. PG Harper C Trask RL Souhami 1984 Avascular necrosis of bone caused by combination chemotherapy without corticosteroids Br Med J (Clin Res Ed) 288 6413 267 268 10.1136/bmj.288.6413.267 1:STN:280:DyaL2c7gsFGqtQ%3D%3D
46. JE Budoff 2006 Concomitant Kienböck's and Preiser's diseases: a case report J Hand Surg Am 31 7 1149 1153 10.1016/j.jhsa.2006.04.003 16945718 (Pubitemid 44291939)
47. H Kato T Ogino A Minami 1991 Steroid-induced avascular necrosis of the capitate. A case report Handchir Mikrochir Plast Chir. 23 1 15 17 1:STN:280:DyaK3M3jsF2quw%3D%3D 2032629
48. RW Culp JL Schaffer AL Osterman FW Bora Jr 1989 Kienböck's disease in a patient with Crohn's enteritis treated with corticosteroids J Hand Surg Am 14 2 Pt 1 294 296 10.1016/0363-5023(89)90024-5 1:STN:280:DyaL1M7pvVeqtQ%3D%3D 2703678
49. L Winters K Habin J Gallagher 2007 Aromatase inhibitors and musculoskeletal pain in patients with breast cancer Clin J Oncol Nurs 11 3 433 439 10.1188/07.CJON.433-439 17623627
50. N Nemitz PT Kurmann D Van Linthoudt 2008 Intensification of a diffuse chronic pain syndrome by the introduction of an aromatase inhibitor Praxis (Bern 1994) 97 3 137 141 10.1024/1661-8157.97.3.137 1:STN:280:DC%2BD1czotFWltQ%3D%3D (Pubitemid 351262117)
51. RE Coleman WW Bolten M Lansdown S Dale C Jackisch D Merkel N Maass P Hadji 2008 Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations Cancer Treat Rev 34 3 275 282 10.1016/j.ctrv.2007.10. 004 1:CAS:528:DC%2BD1cXls12qu70%3D 18082328 Epub 2007 Dec 21
52. HJ Burstein 2007 Aromatase inhibitor-associated arthralgia syndrome Breast 16 3 223 234 10.1016/j.breast.2007.01.011 17368903 Epub 2007 Mar 21 (Pubitemid 46796859)
53. D Saadoun DA Landau LH Calabrese PP Cacoub 2007 Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation Rheumatology (Oxford) 46 8 1234 1242 10.1093/rheumatology/ kem132 1:CAS:528:DC%2BD2sXos12itbY%3D Epub 2007 Jun 12 (Pubitemid 47244492)
54. MA Hamidou A Boumalassa C Larroche D El Kouri O Blétry JY Grolleau 2001 Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia Semin Arthritis Rheum 31 2 119 126 10.1053/sarh.2001. 27717 1:STN:280:DC%2BD3MrksVWlug%3D%3D 11590581 (Pubitemid 32988971)
55. Z Simon T Tarr L Tóth G Szucs A Illés 2008 Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma Rheumatol Int 28 7 719 723 10.1007/s00296-007-0513-4 18092165 Epub 2007 Dec 19
56. N Sato H Tsubochi K Kishimoto T Imai M Kaimori 2007 Anti-neutrophil cytoplasmic anti body (ANCA)-negative limited form of Wegener's granulomatosis: report of a case Kyobu Geka 60 7 591 594 17642224
57. MA Hamidou S Derenne MA Audrain JM Berthelot A Boumalassa JY Grolleau 2000 Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study Rheumatology (Oxford) 39 4 417 420 10.1093/rheumatology/39.4.417 1:STN:280: DC%2BD3c3nvVejsw%3D%3D
58. M Wong J Grossman BH Hahn A La Cava 2008 Cutaneous vasculitis in breast cancer treated with chemotherapy Clin Immunol 129 1 3 9 10.1016/j.clim.2008.07. 001 1:CAS:528:DC%2BD1cXhtFansLzF 18640073 Epub 2008 Jul 21
59. AA Muslimani TP Spiro AA Chaudhry HC Taylor IJ Do HA Daw 2009 Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Clin Breast Cancer 9 1 34 38 10.3816/CBC.2009.n. 006 1:CAS:528:DC%2BD1MXksF2kur4%3D 19299238